$91.71
0.840.92%
At Close: -
15 minutes delayed
Sector
Healthcare
Region
US
AUM
6.87B
Fund Score
SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI) Quotes, Forecast and News Summary
SPDR Series Trust SPDR S&P Biotech ETF (ARCA: XBI) stock price, news, charts, stock research, profile.
| Open | $90.86 |
| High | $91.92 |
| 52 Wk High | 103.52 |
| AUM | 6.87B |
| Volume | 5.56M |
| Avg. Volume Daily | 8.09M |
| Beta | 0.95 |
| P/E Ratio | 15.69 |
| Prev. Close | $90.87 |
| Low | $90.28 |
| 52 Wk Low | 63.80 |
| Mgmt Fee | 0.35% |
| Market Cap | $14.42B |
| Avg. Expense Ratio | 0.35% |
| Shares Out | 75.22M |
| P/B Ratio | 4.05 |
| Dividend | $0.26 |
| Ex-Div Date | Jun 24, 2024 |
| Yield | 0.28% |
| Div. Freq | Quarterly |
FAQ
How do I buy SPDR Series Trust SPDR S&P Biotech ETF (XBI) stock?
You can purchase shares of SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI) through any online brokerage.
Who are SPDR Series Trust SPDR S&P Biotech ETF (XBI) competitors?
There are no as such competitors for SPDR Series Trust SPDR S&P Biotech ETF.
What is the target price for SPDR Series Trust SPDR S&P Biotech ETF (XBI) stock?
There is no analysis for SPDR Series Trust SPDR S&P Biotech ETF.
What is the forecast for SPDR Series Trust SPDR S&P Biotech ETF (XBI) stock?
There is no analysis for SPDR Series Trust SPDR S&P Biotech ETF to provide a consensus price target.
Current stock price for SPDR Series Trust SPDR S&P Biotech ETF (XBI)?
The stock price for SPDR Series Trust SPDR S&P Biotech ETF (ARCA: XBI) is $91.71 last updated Today at July 5, 2024 at 8:00 PM EDT.
Does SPDR Series Trust SPDR S&P Biotech ETF (XBI) pay a dividend?
A quarterly cash dividend of 0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on September 26, 2018 to stockholders of record on September 21, 2018.
When is SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI) reporting earnings?
SPDR Series Trust SPDR S&P Biotech ETF does not have any upcoming earnings scheduled.
Is SPDR Series Trust SPDR S&P Biotech ETF (XBI) going to split?
There is no upcoming split for SPDR Series Trust SPDR S&P Biotech ETF.
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Small Cap Growth |
| Fund Inception | Jan 31, 2006 |
| Managers | Raymond Donofrio Karl A. Schneider |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| NVAX | Novavax Inc | 3.06% |
| INSM | Insmed Inc | 2.19% |
| MRNA | Moderna Inc | 1.53% |
| DYN | Dyne Therapeutics Inc | 1.33% |
| NTRA | Natera Inc | 1.33% |
| RVMD | Revolution Medicines I... | 1.32% |
| PTCT | Ptc Therapeutics Inc | 1.29% |
| BPMC | Blueprint Medicines Co... | 1.27% |
| UTHR | United Therapeutics Co... | 1.26% |
| TWST | Twist Bioscience Corp. | 1.24% |